Answers are grounded in this paper and cite their sources.
First-24-hour hypernatremia–hyperkalemia co-occurrence may mark severe illness, but its incremental prognostic value is uncertain. We analyzed 13,383 adult ICU admissions (11,942 patients) in Taiwan during 2018–2020. Peak sodium > 145 and potassium > 5.5 mmol/L defined four phenotypes; peaks need not be simultaneous. This prognostic association analysis used information accumulated during the first ICU day. Patient-clustered logistic regression compared total APACHE II adjustment with complementary adjustment excluding its sodium/potassium points. Twenty repeated patient-grouped five-fold cross-validations assessed discrimination. Thirty-day mortality was 12.2%, 33.7%, 32.7%, and 74.4% in the neither ( n = 12,097), hypernatremia-only ( n = 841), hyperkalemia-only ( n = 367), and co-occurrence ( n = 78) groups. With total APACHE II, the co-occurrence odds ratio was 1.90 (95% CI 1.07–3.39), global phenotype P = 0.094, and mean AUC change 0.00007. With component-excluded adjustment, the corresponding odds ratio was 2.70 (1.53–4.75), global P = 0.002, and mean AUC change 0.00037. Additional sensitivity analyses examined outcome availability, in-hospital mortality, sparse data, and alternative thresholds. Outcome missingness and unavailable measurement/death timing limit interpretation. Co-occurrence characterized a small high-risk subgroup, but incremental discrimination was negligible; causality and clinical predictive utility were not established.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: